Identity
HGNC
LOCATION
4q22.1
LOCUSID
ALIAS
ABC15,ABCP,BCRP,BCRP1,BMDP,CD338,CDw338,EST157481,GOUT1,MRX,MXR,MXR-1,MXR1,UAQTL1
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 9429
MIM: 603756
HGNC: 74
Ensembl: ENSG00000118777
Variants:
dbSNP: 9429
ClinVar: 9429
TCGA: ENSG00000118777
COSMIC: ABCG2
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA10204 | tenofovir | Chemical | ClinicalAnnotation | associated | PK | 28462920 | |
| PA10804 | imatinib | Chemical | ClinicalAnnotation, VariantAnnotation, VipGene | associated | PK | PD | 18981009, 24123600, 24322003, 30713339 |
| PA128406956 | fluorouracil | Chemical | ClinicalAnnotation | associated | PD | 20530282, 24018773, 24338217 | |
| PA130620651 | anthracyclines and related substances | Chemical | VipGene | associated | 24021215 | ||
| PA131285527 | oxaliplatin | Chemical | ClinicalAnnotation | associated | PD | 20530282, 24338217 | |
| PA131301952 | gefitinib | Chemical | ClinicalAnnotation | associated | PD | 17148776, 20035425, 21332310, 25554506 | |
| PA133950441 | hmg coa reductase inhibitors | Chemical | Literature, MultilinkAnnotation, Pathway | associated | 25084202 | ||
| PA134308647 | rosuvastatin | Chemical | ClinicalAnnotation, DataAnnotation, LabelAnnotation, VipGene | associated | PK | PD | 19474787, 16784736, 18617601, 19474787, 20130569, 20207952, 20679960, 22331829, 23930675, 25630984, 28322941 |
| PA134865839 | SLCO1B1 | Gene | DataAnnotation | associated | |||
| PA151958383 | Gastrointestinal Stromal Tumors | Disease | ClinicalAnnotation | associated | PD | 30713339 | |
| PA151958596 | curcumin | Chemical | VipGene | associated | 25587128 | ||
| PA162372840 | sunitinib | Chemical | ClinicalAnnotation, VipGene | associated | PK | PD | 24013576, 25344452, 26244574 |
| PA162372878 | dasatinib | Chemical | ClinicalAnnotation, VariantAnnotation, VipGene | associated | PD | 24322003 | |
| PA164712948 | Opioid anesthetics | Chemical | ClinicalAnnotation | associated | PD | 30136624 | |
| PA164713083 | Other general anesthetics | Chemical | ClinicalAnnotation | associated | PD | 30136624 | |
| PA164713176 | Platinum compounds | Chemical | Pathway | associated | 19525887 | ||
| PA164760843 | deferasirox | Chemical | ClinicalAnnotation | associated | PK | PD | 27043265, 27193993, 28346059 |
| PA164924562 | elacridar | Chemical | VipGene | associated | |||
| PA165110729 | rhodamine 123 | Chemical | VipGene | associated | 11559526 | ||
| PA165110775 | SN-38 | Chemical | Pathway | associated | |||
| PA165291492 | pazopanib | Chemical | MultilinkAnnotation | associated | 25504632 | ||
| PA165958345 | nilotinib | Chemical | ClinicalAnnotation, VariantAnnotation, VipGene | associated | PD | 24322003 | |
| PA166114961 | dolutegravir | Chemical | ClinicalAnnotation | associated | PK | 28858994 | |
| PA166131630 | volatile anesthetics | Chemical | ClinicalAnnotation | associated | PD | 30136624 | |
| PA166154579 | rs4149056 | Variant | LabelAnnotation | associated | |||
| PA166156544 | rs2231142 | Variant | LabelAnnotation | associated | |||
| PA166163418 | rucaparib | Chemical | LabelAnnotation | associated | |||
| PA166163740 | apixaban | Chemical | ClinicalAnnotation | associated | PK | 28678049, 29457840 | |
| PA166184498 | ezetimibe / rosuvastatin | Chemical | LabelAnnotation | associated | |||
| PA378 | NR1I2 | Gene | Pathway | associated | 21151855 | ||
| PA443434 | Arthritis, Rheumatoid | Disease | ClinicalAnnotation | associated | PD | 20386493, 24394199, 27217051 | |
| PA443459 | Atrial Fibrillation | Disease | ClinicalAnnotation | associated | PK | 28678049, 29457840 | |
| PA443557 | Brain Neoplasms | Disease | ClinicalAnnotation | associated | PK | 27052877 | |
| PA443560 | Breast Neoplasms | Disease | ClinicalAnnotation | associated | PD | ||
| PA443622 | Carcinoma, Non-Small-Cell Lung | Disease | ClinicalAnnotation | associated | PD | 18221820 | |
| PA443658 | Central Nervous System Infections | Disease | ClinicalAnnotation | associated | PK | 29873816 | |
| PA443937 | Drug Toxicity | Disease | ClinicalAnnotation | associated | PD | 30713339 | |
| PA444065 | Epilepsy | Disease | ClinicalAnnotation | associated | PK | PD | 26213157, 27610747, 29791014 |
| PA444101 | Esophageal Neoplasms | Disease | VipGene | associated | |||
| PA444318 | Gout | Disease | ClinicalAnnotation | associated | PD | 26810134, 29341237, 30924126 | |
| PA444516 | Hypercholesterolemia | Disease | ClinicalAnnotation | associated | PK | PD | 16784736, 19474787, 20130569, 20207952, 20679960, 23930675, 25630984, 28322941 |
| PA444818 | Lung Neoplasms | Disease | ClinicalAnnotation | associated | PD | 17148776, 20035425, 21332310, 25554506 | |
| PA445019 | Myocardial Infarction | Disease | ClinicalAnnotation | associated | PK | PD | 16784736, 19474787, 20130569, 20207952, 20679960, 23930675, 25630984, 28322941 |
| PA445062 | Neoplasms | Disease | ClinicalAnnotation | associated | PK | PD | 24013576, 25344452, 26244574 |
| PA445451 | Psoriasis | Disease | ClinicalAnnotation | associated | PD | 18256692 | |
| PA445601 | Osteosarcoma | Disease | ClinicalAnnotation | associated | PK | PD | 25778468, 29791011 |
| PA445742 | Stomach Neoplasms | Disease | VipGene | associated | |||
| PA446108 | Colorectal Neoplasms | Disease | ClinicalAnnotation, VipGene | associated | PD | 20530282, 24018773, 24338217 | |
| PA446171 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Disease | ClinicalAnnotation | associated | PD | 24123600 | |
| PA446432 | beta-Thalassemia | Disease | ClinicalAnnotation | associated | PK | PD | 27043265, 27193993, 28346059 |
| PA447230 | HIV | Disease | ClinicalAnnotation | associated | PK | PD | 23859571, 28462920, 28858994 |
| PA448320 | allopurinol | Chemical | ClinicalAnnotation, VariantAnnotation, VipGene | associated | PD | 26810134, 29341237, 30924126 | |
| PA448500 | atorvastatin | Chemical | ClinicalAnnotation, VipGene | associated | PK | PD | 19474787 |
| PA448771 | capecitabine | Chemical | ClinicalAnnotation | associated | PD | 20530282, 24338217 | |
| PA448866 | ceftriaxone | Chemical | ClinicalAnnotation | associated | PK | 29873816 | |
| PA449165 | cyclophosphamide | Chemical | ClinicalAnnotation | associated | PD | ||
| PA449167 | cyclosporine | Chemical | VipGene | associated | |||
| PA449212 | daunorubicin | Chemical | VipGene | associated | 24021215 | ||
| PA449383 | docetaxel | Chemical | Pathway | associated | 21151855 | ||
| PA449412 | doxorubicin | Chemical | ClinicalAnnotation, VipGene | associated | PD | 11956086 | |
| PA449441 | efavirenz | Chemical | ClinicalAnnotation | associated | PD | 23859571 | |
| PA449688 | fluvastatin | Chemical | ClinicalAnnotation, VipGene | associated | PK | 19842935 | |
| PA449748 | gemcitabine | Chemical | ClinicalAnnotation | associated | PD | ||
| PA450085 | irinotecan | Chemical | ClinicalAnnotation | associated | PD | 18221820, 24018773 | |
| PA450163 | lamivudine | Chemical | Pathway | associated | |||
| PA450164 | lamotrigine | Chemical | ClinicalAnnotation | associated | PK | PD | 26213157, 27610747, 29791014 |
| PA450198 | leucovorin | Chemical | ClinicalAnnotation | associated | PD | 20530282, 24018773, 24338217 | |
| PA450428 | methotrexate | Chemical | ClinicalAnnotation, Pathway, VipGene | associated | PK | PD | 18237272, 18256692, 20386493, 21317831, 25778468, 27217051, 29791011 |
| PA450761 | paclitaxel | Chemical | Pathway | associated | 21151855 | ||
| PA451089 | pravastatin | Chemical | Pathway, VipGene | associated | 19842935 | ||
| PA451363 | simvastatin | Chemical | ClinicalAnnotation, Literature, MultilinkAnnotation, VipGene | associated | PK | 19842935, 24598718 | |
| PA451547 | sulfasalazine | Chemical | ClinicalAnnotation, MultilinkAnnotation, VipGene | associated | PK | PD | 18167504, 24394199, 25872459, 28322941 |
| PA451729 | topotecan | Chemical | ClinicalAnnotation, VipGene | associated | PK | 27052877 | |
| PA451954 | zidovudine | Chemical | Pathway | associated | 22960662 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37793994 | 2024 | Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy. | 0 |
| 38012078 | 2024 | Carboranes as Potent Phenyl Mimetics: A Comparative Study on the Reversal of ABCG2-Mediated Drug Resistance by Carboranylquinazolines and Their Organic Isosteres. | 0 |
| 38181789 | 2024 | ABCG2 is an itaconate exporter that limits antibacterial innate immunity by alleviating TFEB-dependent lysosomal biogenesis. | 2 |
| 38409918 | 2024 | NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression. | 1 |
| 38423481 | 2024 | Roles of breast cancer resistance protein and organic anion transporting polypeptide 2B1 in gastrointestinal toxicity induced by SN-38 under inflammatory conditions. | 0 |
| 38426604 | 2024 | Adipocyte‑rich microenvironment promotes chemoresistance via upregulation of peroxisome proliferator‑activated receptor gamma/ABCG2 in epithelial ovarian cancer. | 1 |
| 38442133 | 2024 | ABCG2 transporter reduces protein aggregation in cigarette smoke condensate-exposed A549 lung cancer cells. | 0 |
| 38451012 | 2024 | ABCG2 polymorphisms and susceptibility to ARV-associated hepatotoxicity. | 1 |
| 38542090 | 2024 | ABCG2 Expression as a Potential Survival Predictor in Human Gliomas. | 0 |
| 37793994 | 2024 | Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy. | 0 |
| 38012078 | 2024 | Carboranes as Potent Phenyl Mimetics: A Comparative Study on the Reversal of ABCG2-Mediated Drug Resistance by Carboranylquinazolines and Their Organic Isosteres. | 0 |
| 38181789 | 2024 | ABCG2 is an itaconate exporter that limits antibacterial innate immunity by alleviating TFEB-dependent lysosomal biogenesis. | 2 |
| 38409918 | 2024 | NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression. | 1 |
| 38423481 | 2024 | Roles of breast cancer resistance protein and organic anion transporting polypeptide 2B1 in gastrointestinal toxicity induced by SN-38 under inflammatory conditions. | 0 |
| 38426604 | 2024 | Adipocyte‑rich microenvironment promotes chemoresistance via upregulation of peroxisome proliferator‑activated receptor gamma/ABCG2 in epithelial ovarian cancer. | 1 |
Citation
Dessen P
ABCG2 (ATP binding cassette subfamily G member 2 (Junior blood group))
Atlas Genet Cytogenet Oncol Haematol. 2003-02-01
Online version: http://atlasgeneticsoncology.org/gene/546/abcg2-(atp-binding-cassette-subfamily-g-member-2-(junior-blood-group))
